Contact us
Contact us
Highlights
Expanded menstrual blood-derived mesenchymal stem cells. For research use only. Manufactured in BSL-2 laboratory in Singapore.
Try them → WaitlistMISEV2023 aligned MenSC-derived extracellular vesicles. For research use only. Manufactured in BSL-2 laboratory in Singapore.
Join the waitlist → PilotA laboratory-based snapshot of uterine health, piloting now with partner clinics.
Join the pilot →Our mission is to make menstrual blood-derived stem cells a practical, scalable source for women's health treatments.
Our vision is a future where regenerative therapies expand what's treatable in women's health.
Backed by
Key partners
Who we work with
The foundation of our science
The 2007 review that first laid out the evidence for stem/progenitor cells in the human endometrium — the basis for the field. Curr Opin Obstet Gynecol, 2007.
Read the paper →A review of menstrual blood-derived stem cells' proliferation, differentiation and immunomodulatory properties across preclinical models. Stem Cell Res Ther, 2018.
Read the paper →A head-to-head comparison of mesenchymal stem cell biology across bone marrow, adipose and other adult tissue sources. Asian Pac J Trop Med, 2015.
Read the paper →A review of MenSC-derived small extracellular vesicles and their emerging role in regenerative medicine. Stem Cell Res Ther, 2021.
Read the paper →A 2025 review covering MenSC-derived extracellular vesicles as tools for tissue regeneration and diagnostics. Front Bioeng Biotechnol, 2025.
Read the paper →Whether it is trying our products, running a menstrual blood lab test pilot for your clinic or researching with us — start with an email and we'll route it to the right person.
